The HighLife team is looking forward to connecting with you in Paris during EuroPCR.
Don’t miss the opportunity to discover the latest clinical data and experience during the 2 following
presentations on Wednesday, May 17 from 8:30 to 10:00 am.
- HighLife transseptal mitral valve replacement: first-in-man primary end-point outcomes. S. Worthley. (Late-Breaking clinical data: mitral and tricuspid valves disease – Room Maillot)
- HighLife transseptal mitral valve replacement : first 30 patients one-year follow-up. L. Schneider (Mitral and tricuspid valve intervention : new devices and clinical outcomes – Interactive case corner #2A)